about
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesCXCR7 functions as a scavenger for CXCL12 and CXCL11Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisCXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasisMicroenvironmental regulation of metastasisChemokines as therapeutic targets in renal cell carcinomaCXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.Tumors as organs: complex tissues that interface with the entire organismRole of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionHGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells.CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1.Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer.Breast cancer metastasis to the central nervous systemThe Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4.CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisActivation of CXCR4 triggers ubiquitination and down-regulation of major histocompatibility complex class I (MHC-I) on epithelioid carcinoma HeLa cells.Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implicationsOlfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.Structure-based drug design: from nucleic acid to membrane protein targets.Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasisAEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells.The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancerSurvival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progressionThe phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinoma.Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo.CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer.The chemokine and chemokine receptor superfamilies and their molecular evolutionPattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions.Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature.Chemokines: novel targets for breast cancer metastasisCalcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.
P2860
Q26866236-A20A57A1-599C-42B5-8401-951D8E984FCBQ27334618-74BBA4C2-72EC-4A39-AC1C-B36AFEC64012Q28260997-FEF21BB1-714F-428F-9A50-873FA45479CAQ28304012-91BF522E-10BA-48BE-9060-9344DAB36ED8Q29547660-8197D18A-2A05-40BF-83E7-D48FD2723B52Q30435873-89224347-57A1-4C63-8AFD-13B9736E0DCFQ30439235-635DC009-1939-4907-BF53-AFAA48D667FBQ30495528-A339A805-8ED4-4751-8CBB-F2D58F3AEBBAQ34090617-A2C430DD-2A22-4657-9A5C-9BC35E6FE77BQ34126591-251058EC-6AFE-4E3E-8547-E755B4D0B47AQ34299243-4D173710-414B-4170-9E54-0715DA5D5893Q34343657-F713FE7B-E06A-4058-B2D5-8D536E4EEBF8Q34455205-9D68AA19-9E4B-47C2-BD70-506DF5EC849AQ34575941-9FCC563E-2A7A-462C-8720-AF8A4BC7A9C4Q34654463-BF99E669-EE0E-46AF-863D-3FFEEBA685EAQ34726071-C8F961DF-0ADD-4E15-9010-7925C0F7C11DQ35055217-2683902E-7EC5-4232-A02F-343B54ECD8E5Q35083529-E67CCDAC-A8CA-42FA-98C6-BC617670501EQ35110710-0050838F-8457-4528-9BB9-255BA13822A7Q35127680-2906D6D1-6DFD-4D02-BE4E-7934BFBDB35EQ35131138-798C00F9-06B8-45EB-A94F-A17E1D4866A6Q35190395-5D199DC3-5239-44D1-A91B-F9A7D0F61324Q35684577-03E84976-510C-44C9-A0EF-F38E1E20A04CQ35754593-816C3C07-7639-473D-ACDF-CD4103566642Q35794892-5953E82B-C3C2-42B3-9DE7-8851184E24ABQ35833218-4A7E48EB-2870-4514-B54D-AA295AA1CA2FQ35940908-EE514127-7ACA-4590-AA82-5B388F6CD4BBQ35971514-462188FB-CF12-4F81-8D3F-C2E8D60D918DQ35973628-F74C4B55-A677-486D-A39B-085FEFF18109Q36219713-937BBDA6-4F4B-403D-BF54-9C4BED4B33A3Q36299200-51262C37-0D2C-477A-84DD-D2704C7465EDQ36370665-91081E1E-7CE4-4E4D-B2F7-DE7DC671FF98Q36485293-2D0E43A7-4DB0-40A6-A8A5-6D5FC1530819Q36502337-CCCF74C8-AA16-4EF5-BCAF-5CB1112D7772Q36698659-2B394F0B-10D4-4BA6-B7AD-EB993DD27BAEQ36798278-EDBD0C7E-FCAF-4FE0-AD12-DA7FCE934C54Q36843035-4B1EB89C-9235-4B20-A15E-57E9A9816D21Q36882877-89A04D5F-3E18-4604-BF38-462A5CA32ADBQ36918688-DD521324-EDEC-49F9-B1E5-168A25BA4BFAQ36985818-9A7FD15C-6D9F-451D-939F-E0977D395EBF
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chemokines in neoplastic progression.
@ast
Chemokines in neoplastic progression.
@en
type
label
Chemokines in neoplastic progression.
@ast
Chemokines in neoplastic progression.
@en
prefLabel
Chemokines in neoplastic progression.
@ast
Chemokines in neoplastic progression.
@en
P1476
Chemokines in neoplastic progression.
@en
P2093
Albert Zlotnik
P304
P356
10.1016/J.SEMCANCER.2003.10.004
P577
2004-06-01T00:00:00Z